Details from NCBI annotation

Gene Symbol Gart
Gene Name phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase, transcript variant X7
Entrez Gene ID 101697318

Database interlinks

Part of NW_004624745.1 (Scaffold)

For more information consult the page for NW_004624745.1 (Scaffold)

Potential Gene Matches

The following genes have been identified as possible homologs of the naked mole-rat gene and compared to it.

GART ENSCPOG00000005160 (Guinea pig)

Gene Details

phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase

External Links

Gene Match (Ensembl Protein ID: ENSCPOP00000004641, Guinea pig)

Protein Percentage 90.4%
CDS Percentage 90.07%
Ka/Ks Ratio 0.23863 (Ka = 0.06, Ks = 0.2513)

GART ENSG00000159131 (Human)

Gene Details

phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase

External Links

Gene Match (Ensembl Protein ID: ENSP00000371253, Human)

Protein Percentage 88.71%
CDS Percentage 87.92%
Ka/Ks Ratio 0.18021 (Ka = 0.0649, Ks = 0.3604)

Gart ENSMUSG00000022962 (Mouse)

Gene Details

phosphoribosylglycinamide formyltransferase

External Links

Gene Match (Ensembl Protein ID: ENSMUSP00000023684, Mouse)

Protein Percentage 86.93%
CDS Percentage 83.73%
Ka/Ks Ratio 0.13305 (Ka = 0.0778, Ks = 0.5847)

Gart ENSRNOG00000028292 (Rat)

Gene Details

phosphoribosylglycinamide formyltransferase (Gart), mRNA

External Links

Gene Match (Ensembl Protein ID: ENSRNOP00000033253, Rat)

Protein Percentage 87.13%
CDS Percentage 83.83%
Ka/Ks Ratio 0.13628 (Ka = 0.0786, Ks = 0.5765)

Genome Location

Sequence Coding sequence

Length: 3033 bp    Location: 21763375..21735368   Strand: -
>XM_004842324.1
ATGGCAGCCCGCGTACTTGTAATTGGCAGTGGAGGAAGGGAACATACACTGGCCTGGAAACTGGCACAGTCTCCTCGTGTCAAACAAGTATTGGTTGCCCCAGGAAATGCAGGCACTGCCTGCTTGGAAAAGATTTCAAATACTGCCATCTCAGTTGGTGATCATACAGCCCTTGCTCAGTTCTGCAAAGATGAGAAGGTTGCATTCGTAGTTGTTGGACCAGAGGCACCTCTGGCTGCCGGAATTGTTGGGGACTTGGCCTCTGCAGGAGTGCGATGCTTTGGCCCCACTGCAGAAGCAGCTCAGTTAGAGTCCAGCAAAAGGTTTGCCAAAGAGTTTATGGACCGACATAGAATCCCAACTGCACAGTGGAGAGCTTTCACCAAAGCTGAGAAGGCCTGCAGCTTCATCATGAGTGCTGACTTCCCTGCTCTGGTTGTGAAGGCCAGCGGCCTTGCGGCTGGGAAGGGAGTGATTGTTGCAAAGAGCAAAGAAGAGGCCTGCAAAGCTGTACAGGAGATCATGCAGGAGAAAACTTTTGGAGCAGCTGGAGAAACAGTTGTTGTTGAAGAACTTCTTGAAGGGGAAGAGGTGTCTTGTCTGTGTTTCACCGACGGGAGGACAGTGGTCCCCATGCCCCCAGCCCAGGACCATAAGCGATTACTGGAAGGAGATCTGGGACCCAACACGGGGGGAATGGGAGCCTATTGTCCAGCACCCCAGATTTCCAAGGATTTGTTACTAAAAATTAAAAATACTATTCTTCAGAGGACAGTAGATGGCATGCAGCAAGAGGGCACTCCGTACACAGGAATTCTGTATGCTGGTATAATGCTGACCAAGGATGGCCCAAAAGTCTTGGAGTTTAATTGCCGTTTTGGTGATCCAGAGTGCCAAGTAATCCTCCCACTTCTTAAAAGTGATCTTTATGAAGTGATTCAGTCTACCTTAGATGGCCTGCTGTGTTCATCTCTGCCCAGTTGGCTAGAAAACCATACTGCGGTGACTGTCGTCATGGCAAGCAAAGGTTATCCTGGAGCCTACACCAAGGGCATGGAGATTACAGGCATTCCCGAAGCTCAGGCTTTAGGACTGGAGGTATTCCACGCAGGCACTGCCCTCAAAGATGGGAAAGTAGTAACCAGCGGGGGCAGAGTGCTCACAGTAACAGCCATCCGGGAAAATCTCAAATCAGCTCTTGAGGAAGCCAAGAAGGGACTCGCCACTATCAAGTTTGAGGGAGCTGTTTATAGGAAGGACATCGGCTTTCATGCCATAGCTTTCCTCCAGCAGCCCAGGGGCCTGACTTACAAAGACTCTGGGGTAGACATTGCAGCTGGAAATATGCTGGTTAAGAAAATTCAGCCTTTAGCAAAAGCTACCTCCAGACCTGGCTGTGATGTTGATCTTGGAGGTTTTGCTGGTCTTTTTGATTTGAAAGCAGCTGGTTTCAAAGATCCTCTTCTGGCCTCTGGGACAGATGGTGTTGGGACTAAACTGAAGATTGCCCAGCTGTGCAATAAGCACAGTACCATTGGTCAAGATTTGGTTGCAATGTGTGTAAATGACATTCTGGCGCAAGGAGCAGAGCCCCTCTTTTTCCTTGATTATTTTTCCTGTGGAAAACTTGACCTCAGGACGACGGAAGCTGTTGTTGCTGGAGTCGCTGAGGCTTGTAAACAAGCTGGGTGTGCTCTGCTAGGAGGTGAAACGGCAGAGATGCCAGACATGTATCCTCCTGGAGAGTATGACCTAGCGGGTTTTGCTGTCGGTGGCATGGAGCGGTACCAGAAACTCCCTCACCTGGAACAGATCGTGGAAGGGGATGTTGTTGTTGGAATAGCCTCATCTGGTCTTCATAGCAATGGATTTAGCCTTGTGAGGAAAATTGTGGCACAGTCTTCACTGGAATACTCCTCTCTAGCACCTGGTGGCTGTGGTGACCAGACTTTAGGAGACTTACTTCTAACTCCAACCAGAATCTACAGCCGTTCACTGTTACCTGTCATACGTTCAGGACTTGTCAAGGCCTTTGCCCATATTACTGGTGGAGGCTTGCTAGAAAACATTCCCAGAGTCCTCCCTAAGAAATTTGGGGTGGATTTAGATGCCCGCACCTGGAGGATCCCCAGAGTCTTTTCATGGTTACAGCAGGAAGGGCAGCTCTCTGAAGAAGAGATGGCCAGAACATTTAACTGTGGAGTTGGAGCTGCCCTGGTGGTTTCAAAAGATCAGACGGATCACATTCTGAGAGAGATTCAGCAGCGGCAGGAGGAGGCCTGGGTGATTGGCAGTGTGGTTGCATGCCCTGAAGGTTCCCCACGTGTGAAAGTCAAGAATCTGATTGAAACCATGCAAATAAATGAGTCGGTGTTGGTGAATGGCTCCCTGGAAACTCATTTCCCTGCCCAACAAAAAAAGGCAAGAGTGGCCGTCTTGATATCTGGAACAGGATCAAACCTCCAGGCACTTATAGACAGCACTCAGGATCCAAACAGTGCTGCTCACATTGTTGTCGTTATCTCCAACAAACCCGCAGTGGCTGGATTAAACAAAGCTGAAAAAGCTGGTATTCCCACCAGAGTAATTAATCACAAATTATATAAAAATCGTGAAGAATTTGACGGTGCCATTGACCAGGTGCTTGAAGAGTTTGCCACAGACATAGTCTGTCTTGCAGGATTCATGAGAATTCTATCTGGCCCCTTTGTCAGAAAATGGGATGGGAAAATGCTCAATATCCACCCATCACTGCTCCCTTCTTTTAAGGGTTCAAATGCTCATGAGCAAGTCTTGGAAGCCGGAGTCACAATCACTGGGTGCACCGTGCACTTTGTAGCTGAAGATGTAGATGCTGGACAAATTATTTTACAAGAAGCTGTTCCTGTGAAGAGAGGTGACACTGTTGCAACTTTGTCTGAAAAAGTAAAAGTAGCAGAGCATAAAATATTTCCTAAAGCTCTTCAGCTTGTGGCCAGTGGAACCATATGGCTTGGAGAAAACAACAAGGTCTGTTGGGTCAAAGAAGAATAA

Related Sequences

XP_004842381.1 Protein

Gart PREDICTED: trifunctional purine biosynthetic protein adenosine-3 isoform X7 [Heterocephalus glaber]

Length: 1010 aa      View alignments
>XP_004842381.1
MAARVLVIGSGGREHTLAWKLAQSPRVKQVLVAPGNAGTACLEKISNTAISVGDHTALAQFCKDEKVAFVVVGPEAPLAAGIVGDLASAGVRCFGPTAEAAQLESSKRFAKEFMDRHRIPTAQWRAFTKAEKACSFIMSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKTFGAAGETVVVEELLEGEEVSCLCFTDGRTVVPMPPAQDHKRLLEGDLGPNTGGMGAYCPAPQISKDLLLKIKNTILQRTVDGMQQEGTPYTGILYAGIMLTKDGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCSSLPSWLENHTAVTVVMASKGYPGAYTKGMEITGIPEAQALGLEVFHAGTALKDGKVVTSGGRVLTVTAIRENLKSALEEAKKGLATIKFEGAVYRKDIGFHAIAFLQQPRGLTYKDSGVDIAAGNMLVKKIQPLAKATSRPGCDVDLGGFAGLFDLKAAGFKDPLLASGTDGVGTKLKIAQLCNKHSTIGQDLVAMCVNDILAQGAEPLFFLDYFSCGKLDLRTTEAVVAGVAEACKQAGCALLGGETAEMPDMYPPGEYDLAGFAVGGMERYQKLPHLEQIVEGDVVVGIASSGLHSNGFSLVRKIVAQSSLEYSSLAPGGCGDQTLGDLLLTPTRIYSRSLLPVIRSGLVKAFAHITGGGLLENIPRVLPKKFGVDLDARTWRIPRVFSWLQQEGQLSEEEMARTFNCGVGAALVVSKDQTDHILREIQQRQEEAWVIGSVVACPEGSPRVKVKNLIETMQINESVLVNGSLETHFPAQQKKARVAVLISGTGSNLQALIDSTQDPNSAAHIVVVISNKPAVAGLNKAEKAGIPTRVINHKLYKNREEFDGAIDQVLEEFATDIVCLAGFMRILSGPFVRKWDGKMLNIHPSLLPSFKGSNAHEQVLEAGVTITGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSEKVKVAEHKIFPKALQLVASGTIWLGENNKVCWVKEE